GEHC
GE HealthCare Technologies Inc

2,150
Mkt Cap
$34.76B
Volume
2.24M
52W High
$94.80
52W Low
$57.65
PE Ratio
15.59
GEHC Fundamentals
Price
$77.26
Prev Close
$76.14
Open
$76.32
50D MA
$74.64
Beta
0.79
Avg. Volume
3.73M
EPS (Annual)
$4.34
P/B
3.58
Rev/Employee
$371,169.81
Loading...
Loading...
News
all
press releases
GEHC Stock Up Following Approval to Boost Hemodynamic Monitoring
GE HealthCare secures CE mark for Carevance, advancing scalable, cost-effective monitoring across care settings.
Zacks·1d ago
News Placeholder
More News
News Placeholder
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market
Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market Investors Eye Next-Gen 3D AI-Imaging Technologies in Growing $9 Billion Market PR Newswire NEW YORK, Oct. 21, 2025...
PR Newswire·2d ago
News Placeholder
Carevance platform expands access to GE HealthCares clinical excellence with advanced patient monitoring and new perioperative hypotension management capability
GE HealthCare (Nasdaq: GEHC) today announced it has received CE mark for its Carevance patient monitor, advancing accessible and reliable care for more customers starting in Europe. Built on GE...
Business Wire·2d ago
News Placeholder
GEHC Stock Up Following New Launch to Streamline Perinatal Workflow
GE HealthCare unveils CareIntellect for Perinatal, a SaaS tool aimed at improving maternal and fetal care delivery.
Zacks·8d ago
News Placeholder
GE HealthCare launches CareIntellect for Perinatal, a cloud-first application to optimize care delivery and help send families home healthy
GE HealthCare (Nasdaq: GEHC) today announced the launch of CareIntellect for Perinatal2, a cloud-first Software-as-a-Service (SaaS) application designed to deliver clear, actionable insights that...
Business Wire·9d ago
News Placeholder
University of Michigan study presentation at ANESTHESIOLOGY 2025 supports clinical and environmental benefits of End-tidal Control
GE HealthCare (Nasdaq: GEHC) today announced the presentation of findings from the largest real-world evidence study to-date on End-tidal Control anesthesia delivery* software conducted at the...
Business Wire·10d ago
News Placeholder
U.S.-China Trade Tensions Stiffen: ETF Areas Likely to Lose the Most
As U.S.-China trade tensions intensify again, ETFs like SMH, XLK, TSLT, BJK, XRT, RTH, LGHT, and USO are likely to come under pressure.
Zacks·11d ago
News Placeholder
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.
Zacks·13d ago
News Placeholder
TEM Expands Partnership With Northwestern Medicine Amid AI Boom
Tempus AI deepens its collaboration with Northwestern Medicine, embedding its AI co-pilot David directly into the health system's EHR to boost clinical efficiency.
Zacks·13d ago
News Placeholder
Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?
Tempus AI sharpens its edge in precision medicine with key acquisitions, strong R&D launches, and improving financials amid rising competition.
Zacks·14d ago

Latest GEHC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.